Apple is developing an innovative interface for controlling devices using the power of thought. To implement this project, the technology giant is collaborating with the American startup Syncron, the creator of the Stentrode neuroimplant, snob.ru reports with reference to The Wall Street Journal.

The peculiarity of the Syncron implant is its minimal invasiveness – it is installed through the jugular vein without the need for surgical intervention in the skull. The device reads neural signals associated with movement intentions and converts them into commands for the iPhone, Apple Vision Pro and other devices in the Apple ecosystem. The technology is currently being tested among patients with motor disorders. One of the program participants is already using Apple Vision Pro for communication and entertainment, activating the device's functions with the power of thought.

Although initially aimed at people with disabilities, this development may become part of Apple’s mass products in the future. The first versions of the technology will be compatible with third-party neural implants, and the company plans to develop its own solutions in the future.

Syncron emphasizes the advantage of its technology over competitors such as Neuralink, noting the significantly less traumatic installation procedure, which does not require craniotomy. The device is currently undergoing clinical trials and awaiting approval from the US Food and Drug Administration (FDA).